Fund Details Issuer Roundhill Investments Fund Name Roundhill GLP-1 & Weight Loss ETF Tax Classification Regulated Investment Company Stock Exchange NASDAQ Current Symbol NASDAQ:OZEM Inception Date 5/20/2024 Fund Manager Will Hershey, Tim Maloney, Dave Mazza, Drew Walsh Previous Symbol NASDAQ:OZEM Web N/A Phone N/A Fund Focus Asset Class Equity Benchmark N/A Category Strategy Focus Theme Development Level Blended Development Region Global Number of Holdings 53 Fund Statistics Assets Under Management $0.00 Average Daily Volume $0.00 Discount/Premium 0.00% Administrator, Advisor and Custodian Administrator U.S
I feel fuller, calmer and more energetic
We focus on precisionpairing compounded formulations with biomarker and genetic context to support informed provider conversations
This type of regulation may also account for the observed decrease in NAD + -GDH aminating activity upon exposure to an ammonium pulse
June 18, 2009
When discussing alternatives with your GP, be open about: Your experience with Rybelsus, including both benefits and difficulties Your treatment priorities (glucose control, weight management, convenience, side effect profile) Any concerns about injections if considering injectable GLP-1 agonists Your ability to adhere to different dosing schedules Non-pharmacological approaches remain fundamental to diabetes management regardless of medication choice